Home > Patient Educational Videos > Testicular Cancer - What is the Treatment of Non Seminoma Testicular Cancer?

Treatment of non seminoma testicular cancer


Testicular cancer is the most common solid malignancy affecting males between the ages of 15 and 35, although it accounts for about 1 percent of all cancers in men. Germ cell tumors (GCTs) account for 95 percent of testicular cancers. They may consist of one predominant histologic pattern, or represent a mix of multiple histologic types. 

For treatment purposes, two broad categories of testis tumors are recognized: pure seminoma (no nonseminomatous elements present), and all others, which together are termed nonseminomatous germ cell tumors (NSGCTs). In most series, the ratio of seminoma to NSGCT is about one.

Testicular cancer has become one of the most curable of solid neoplasms because of remarkable treatment advances beginning in the late 1970s.

Here, Dr. Tony Talebi discusses the treatment of non seminoma testicular cancer with Dr. Pasquele Benedetto, professor of medicine at the University of Miami Sylvester Comprehensive Cancer Center, including symptoms, diagnosis, staging, prognosis, surgery, radiation therapy and chemotherapy for non seminoma testicular cancer, Testicular cancer prognosis, what causes Testicular cancer, signs of Testicular cancer, Testicular cancer symptoms, Testicular cancer, Testicular cancer stage 4, treatment of Testicular cancer, Testicular cancer association, stage four Testicular cancer, small cell Testicular cancer, symtoms of Testicular cancer, causes of Testicular cancer, Testicular cancer chemotherapy, what is Testicular cancer, Testicular cancers, Testicular cancer information, Testicular cancer prevention, stage 4 Testicular cancer, information about Testicular cancer, stage iv Testicular cancer, Testicular cancer signs, Testicular cancer symptom, is Testicular cancer curable, stage 3b Testicular cancer, lungs cancer symptoms, survival rates for Testicular cancer, symptoms of Testicular cancer, Testicular cancer survivors, Testicular cancer symptons, Testicular cancer survival, treatments of Testicular cancer, symptons of Testicular cancer, Testicular cancer statistics, non small cell Testicular cancer, chemo for Testicular cancer, Testicular cancer survival rate, large cell Testicular cancer, effects of Testicular cancer, Testicular cancer screening, Testicular cancer diagnosis, Testicular cancer society, Testicular cancer clinical trials, Testicular cancer metastasis, survival rate Testicular cancer, symptom of Testicular cancer, info on Testicular cancer, new treatments for Testicular cancer, how common is Testicular cancer.

.


Dr. Pasquele Benedetto credentials:


Board Certifications:


American Board of Internal Medicine 
American Board of Internal Med-Hematology 
American Board of Internal Med-Medical Oncology


Education:

Georgetown University
Washington, DC		Undergraduate

Weill Medical College of Cornell University
New York, NY		Graduate

Johns Hopkins Hospital
Baltimore, MD		Residency

Memorial Sloan-Kettering Cancer Center
New York, NY		Fellowship